Active Pharmaceutical Ingredients (APIs) and Excipients

Kapil Radadiya
Written by Kapil Radadiya
Active Pharmaceutical Ingredients (APIs) and Excipients

Pharmaceutical formulations generally contain two important categories of ingredients: Active Pharmaceutical Ingredients (APIs) and excipients. Although both contribute to the finished dosage form, they perform fundamentally different functions.

An Active Pharmaceutical Ingredient (API) provides the intended pharmacological activity of a medicine. In contrast, an excipient generally supports the formulation, manufacturing process, stability, appearance, administration or performance of the finished pharmaceutical product.

Understanding the difference between APIs and excipients is important for pharmaceutical formulation, manufacturing, quality control and regulatory compliance.

What Is an Active Pharmaceutical Ingredient (API)?

An Active Pharmaceutical Ingredient (API) is the active substance in a pharmaceutical product that provides its intended pharmacological activity.

Pharmaceutical manufacturers incorporate APIs into different dosage forms, including:

  • Tablets
  • Capsules
  • Oral liquids
  • Injections
  • Creams
  • Gels
  • Ointments
  • Ophthalmic preparations

The amount and type of API depend on the medicine, dosage strength, route of administration and formulation requirements.

For a broader explanation of API terminology, types and manufacturing, read our guide to Active Pharmaceutical Ingredients (APIs).

What Are Pharmaceutical Excipients?

Pharmaceutical excipients are substances included in a pharmaceutical formulation primarily to perform functions other than providing the intended primary pharmacological activity.

Formulators may use excipients to support:

  • Manufacturing
  • Powder flow
  • Tablet formation
  • Disintegration
  • Dissolution
  • Stability
  • Preservation
  • Taste
  • Appearance
  • Drug delivery

The selection of an excipient depends on the dosage form, API characteristics, manufacturing process and applicable quality and regulatory requirements.

Explore a leading manufacturer of APIs.

With over 10 years of expertise, we ensure GMP compliance and provide reliable, high-quality solutions.

What Is the Difference Between APIs and Excipients?

The main difference between an API and an excipient lies in their primary function within the pharmaceutical product.

The API provides the intended pharmacological activity, while excipients generally support the formulation and manufacturing of the finished dosage form.

PropertyActive Pharmaceutical Ingredient (API)Pharmaceutical Excipient
Primary roleProvides intended pharmacological activitySupports formulation and manufacturing
ActivityActive componentGenerally does not provide the primary therapeutic effect
QuantityBased on required dosage strengthBased on formulation requirements
SelectionBased on therapeutic purposeBased on functional requirements
ExamplesParacetamol, Ibuprofen, AdapaleneLactose, Povidone, Magnesium Stearate
Quality requirementsMust meet applicable API specificationsMust meet applicable excipient specifications
Use in formulationProvides active functionHelps create a suitable finished dosage form

Therefore, APIs and excipients perform different but complementary roles in pharmaceutical formulations.

What Is the Role of an API in Pharmaceutical Formulations?

The API provides the intended pharmacological activity of the pharmaceutical product.

For example, when manufacturers formulate a tablet, they combine a specified quantity of API with selected excipients to create the finished dosage form.

The required API concentration depends on factors such as:

  • Dosage strength
  • Route of administration
  • Formulation design
  • Product specification
  • Applicable regulatory requirements

The physical and chemical properties of the API can also influence the selection of excipients and the manufacturing process.

What Is the Role of Excipients in Pharmaceutical Formulations?

Excipients perform several important functions depending on the dosage form.

They can help manufacturers convert an API into a stable, manufacturable and suitable pharmaceutical product.

For example, formulators may select excipients to improve powder flow, bind tablet ingredients, promote tablet disintegration, provide bulk, control viscosity or support product stability.

However, the exact function depends on the individual excipient and formulation.

Common Types of Pharmaceutical Excipients

Pharmaceutical manufacturers use different categories of excipients according to formulation requirements.

Excipient TypeMain FunctionExamples
Diluents/FillersProvide bulkLactose, Mannitol, Microcrystalline Cellulose
BindersHelp hold formulation components togetherPovidone, Starch
DisintegrantsHelp tablets break apartCrospovidone, Sodium Starch Glycolate
LubricantsReduce friction during manufacturingMagnesium Stearate, Stearic Acid
GlidantsImprove powder flowColloidal Silicon Dioxide
PreservativesHelp control microbial deterioration where applicableSodium Benzoate, Parabens
Coating AgentsProvide or support tablet coatingHypromellose
SweetenersImprove tasteSucrose, Sucralose
Chelating AgentsBind certain trace metal ionsDisodium EDTA
Buffers/pH AdjustersHelp establish or maintain suitable pHCitrates, Phosphates

The suitability of any excipient depends on the formulation, dosage form and applicable regulatory requirements.

Examples of APIs and Excipients

A simple way to understand the difference is through examples.

Examples of Active Pharmaceutical Ingredients

Common examples of APIs include:

Each API provides a specific intended pharmacological activity within an appropriate pharmaceutical product.

Examples of Pharmaceutical Excipients

Examples of substances that may function as pharmaceutical excipients include:

  • Lactose
  • Microcrystalline cellulose
  • Povidone
  • Magnesium stearate
  • Mannitol
  • Sodium citrate
  • Disodium EDTA
  • Sodium benzoate

However, the function and regulatory status of a substance depend on its particular application, grade and formulation.

How Do APIs and Excipients Work Together?

APIs and excipients perform complementary functions within pharmaceutical formulations.

A simplified pharmaceutical formulation can be represented as:

API + Suitable Excipients → Pharmaceutical Formulation → Finished Dosage Form

For example, a tablet may contain an API together with a filler, binder, disintegrant, lubricant and coating material.

The API provides the intended active function, while the excipients help manufacturers produce a dosage form with appropriate physical, manufacturing and stability characteristics.

API vs Excipient: Which Is More Important?

It is not useful to classify one as more important than the other because they perform different functions.

The API is essential for the intended pharmacological activity, while properly selected excipients can be essential for creating a suitable finished dosage form.

An unsuitable excipient or an incompatibility between an API and excipient can affect formulation characteristics. Therefore, pharmaceutical development teams evaluate API–excipient compatibility during formulation development where appropriate.

API and Excipient Quality Requirements

Both APIs and pharmaceutical excipients require appropriate quality controls.

Depending on the material, specification and intended market, manufacturers may evaluate parameters such as:

  • Identification
  • Assay
  • Purity
  • Related substances or impurities
  • Moisture or water content
  • Residual solvents, where applicable
  • Elemental impurities, where applicable
  • Microbiological quality, where applicable
  • Physical characteristics

Manufacturers should establish appropriate specifications according to the material, intended use and applicable regulatory or pharmacopoeial requirements.

Pharmacopoeial Standards for APIs and Excipients

Many APIs and excipients have monographs in recognised pharmacopoeias.

Common pharmacopoeias include:

  • Indian Pharmacopoeia (IP)
  • British Pharmacopoeia (BP)
  • United States Pharmacopeia–National Formulary (USP–NF)
  • European Pharmacopoeia (Ph. Eur.)
  • Japanese Pharmacopoeia (JP)

Where an applicable monograph exists, it may define requirements for identification, purity, assay and other quality parameters.

Manufacturers and pharmaceutical companies should determine the applicable specification according to the particular substance, product and target market.

API and Excipient Compatibility

API–excipient compatibility is an important consideration during pharmaceutical formulation development.

Formulation scientists evaluate whether selected excipients could interact physically or chemically with the API under relevant processing and storage conditions.

Compatibility studies may help identify potential issues related to:

  • Chemical degradation
  • Moisture sensitivity
  • Oxidation
  • pH
  • Physical changes
  • Stability
  • Manufacturing performance

The required evaluation depends on the properties of the API, excipients and intended dosage form.

APIs, Excipients and Finished Pharmaceutical Products

These three terms should not be used interchangeably.

API: Provides the intended pharmacological activity.

Excipient: Performs supporting functions within the formulation.

Finished pharmaceutical product: Contains the API together with appropriate excipients in the final dosage form.

For example:

Active Pharmaceutical Ingredient + Excipients → Tablet/Capsule/Liquid/Cream → Finished Pharmaceutical Product

This distinction is particularly important in pharmaceutical manufacturing, quality documentation and regulatory submissions.

Conclusion

Active Pharmaceutical Ingredients (APIs) and excipients perform distinct but complementary roles in pharmaceutical formulations. APIs provide the intended pharmacological activity, while excipients support manufacturing, formulation, stability, administration and other product characteristics.

Understanding the difference between APIs and excipients is therefore fundamental to pharmaceutical formulation and manufacturing.

For a more detailed explanation of API terminology, types, manufacturing and quality requirements, read our guide to Active Pharmaceutical Ingredients (APIs).

FAQs

What is the full form of API in pharmaceuticals?

API stands for Active Pharmaceutical Ingredient.

What is the main difference between an API and an excipient?

An API provides the intended pharmacological activity of a medicine, while an excipient generally performs supporting functions within the formulation or manufacturing process.

Are excipients active pharmaceutical ingredients?

No. Excipients generally do not provide the primary intended pharmacological activity of a pharmaceutical product.

Why are excipients added to medicines?

Formulators add excipients for functions such as providing bulk, binding ingredients, improving powder flow, promoting disintegration, controlling pH, supporting stability or improving other dosage-form characteristics.

Can a pharmaceutical product contain more than one API?

Yes. Some pharmaceutical products contain two or more active pharmaceutical ingredients.

Is Disodium EDTA an API or an excipient?

Disodium EDTA can function as a chelating excipient in suitable pharmaceutical formulations where its use is appropriate and permitted.

What are examples of pharmaceutical excipients?

Examples include lactose, mannitol, microcrystalline cellulose, povidone, magnesium stearate and other substances used for specific formulation functions.

Do APIs and excipients require quality testing?

Yes. Manufacturers establish appropriate specifications and quality controls for APIs and excipients according to their intended use and applicable requirements.